CORONAVIRUS S PROTEIN VARIANT AND USE THEREOF
Provided is an S protein variant, which does not contain a complete cytoplasmic tail domain compared to the S protein of a wild-type coronavirus. Further provided are a nucleic acid molecule encoding the S protein variant, and the use of the S protein variant and the nucleic acid molecule in the pre...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English French |
Published |
14.12.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is an S protein variant, which does not contain a complete cytoplasmic tail domain compared to the S protein of a wild-type coronavirus. Further provided are a nucleic acid molecule encoding the S protein variant, and the use of the S protein variant and the nucleic acid molecule in the preparation of a vaccine.
L'invention concerne un variant de protéine S, qui ne contient pas de domaine de queue cytoplasmique complet par rapport à la protéine S d'un coronavirus de type sauvage. L'invention concerne en outre une molécule d'acide nucléique codant pour le variant de protéine S, et l'utilisation du variant de protéine S et de la molécule d'acide nucléique dans la préparation d'un vaccin.
提供了一种S蛋白变体,与野生型冠状病毒的S蛋白相比,其不包含完整的细胞质尾巴结构域。还提供了编码所述S蛋白变体的核酸分子,以及所述S蛋白变体和核酸分子在制备疫苗中的应用。 |
---|---|
Bibliography: | Application Number: WO2022CN136551 |